Fu-Nan Li
Impact in
-
- Inflammasome and immune disorders
- Cell death mechanisms and regulation
- Peroxisome Proliferator-Activated Receptors
-
- Synthesis and biological activity
- Synthesis and Characterization of Heterocyclic Compounds
Papers in
-
- Ion Channels and Receptors 4
-
- Synthesis and biological activity 4
- Synthesis and Characterization of Heterocyclic Compounds 2
- Co-authors
- Zhi‐Hong Jiang (2 shared papers)Qiao Wu (3 shared papers)Yuan-li Ai (3 shared papers)Hang‐zi Chen (4 shared papers)Bo Zhou (1 shared paper)Weijia Wang (1 shared paper)Dawang Zhou (1 shared paper)Zhe‐Shan Quan (2 shared papers)
- Journals
- Archives of Pharmacal Research (4 papers)Bioorganic & Medicinal Chemistry (3 papers)Molecules (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Journal of Clinical Investigation (1 paper)
- Partner nations
- ChinaSouth Korea
In The Last Decade
Fu-Nan Li
21 papers receiving 604 citations
Fu-Nan Li's Hit Papers
Peers
Comparison fields: 5 of 73
- Molecular Biology 297
- Organic Chemistry 104
- Cancer Research 29
- Sensory Systems 10
- Pharmaceutical Science 13
Countries citing papers authored by Fu-Nan Li
This map shows the geographic impact of Fu-Nan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fu-Nan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fu-Nan Li more than expected).
Fields of papers citing papers by Fu-Nan Li
This network shows the impact of papers produced by Fu-Nan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fu-Nan Li. The network helps show where Fu-Nan Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Fu-Nan Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The metabolite α-KG induces GSDMC-dependent pyroptosis through death receptor 6-activated caspase-8 Hit paper breakdown → | 2021 | 317 |
| 2 | 2018 | 31 | |
| 3 | 2013 | 28 | |
| 4 | 2014 | 25 | |
| 5 | 2005 | 24 | |
| 6 | 2022 | 24 | |
| 7 | 2007 | 23 | |
| 8 | 2008 | 23 | |
| 9 | Synthesis of Novel 7-Substituted-5-phenyl-[1,2,4]triazolo[1,5-a] Pyrimidines with Anticonvulsant Activity. | 2012 | 18 |
| 10 | 2007 | 17 | |
| 11 | 2020 | 13 | |
| 12 | 2009 | 11 | |
| 13 | 2015 | 11 | |
| 14 | 2025 | 11 | |
| 15 | 2013 | 10 | |
| 16 | 2009 | 6 | |
| 17 | 2023 | 6 | |
| 18 | 2025 | 5 | |
| 19 | 2024 | 4 | |
| 20 | 2018 | 3 |
About Fu-Nan Li
Fu-Nan Li is a scholar working on Sensory Systems, Organic Chemistry, Psychiatry and Mental health, Analytical Chemistry and Molecular Biology, having authored 22 papers that have together received 611 indexed citations. Recurring topics across this work include Ion Channels and Receptors (4 papers), Synthesis and biological activity (4 papers), Epilepsy research and treatment (3 papers), Inflammasome and immune disorders (2 papers), Peroxisome Proliferator-Activated Receptors (2 papers), Synthesis and Characterization of Heterocyclic Compounds (2 papers), Bioactive Compounds and Antitumor Agents (1 paper) and Cardiac Ischemia and Reperfusion (1 paper). The work is most often cited by research in Molecular Biology (297 citations), Organic Chemistry (104 citations), Cancer Research (29 citations), Sensory Systems (10 citations) and Pharmaceutical Science (13 citations). Fu-Nan Li has collaborated with scholars based in China and South Korea. Frequent co-authors include Zhi‐Hong Jiang, Qiao Wu, Yuan-li Ai, Hang‐zi Chen, Bo Zhou, Weijia Wang, Dawang Zhou, Zhe‐Shan Quan, Qing Chen and Young‐Ger Suh. Their work appears in journals such as Archives of Pharmacal Research, Bioorganic & Medicinal Chemistry, Molecules, Bioorganic & Medicinal Chemistry Letters and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.